Loading
Established that HPV causes a distinct, better-prognosis form of throat cancer and led RTOG 1016 on how to treat it.
Maura Gillison's work established human papillomavirus as the cause of a rising epidemic of oropharyngeal cancer with a far better prognosis than tobacco-related disease, leading to a separate staging system. She led RTOG 0129 analyses defining HPV as a prognostic factor and RTOG 1016, which showed cetuximab cannot replace cisplatin in HPV-positive disease, a key de-escalation failure. Her work continues on ctDNA and HPV-directed therapy.
Shares Head and neck squamous cell carcinoma and the tags head-and-neck, de-escalation.
Shares RTOG 0129 (HPV analysis), Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination and the tag hpv.
Shares Head and neck squamous cell carcinoma and the tag head-and-neck.
Shares Head and neck squamous cell carcinoma and the tag head-and-neck.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
Shares Head and neck squamous cell carcinoma and the tag head-and-neck.